Almirall, S.A. (BME:ALM)
Spain · Delayed Price · Currency is EUR 12.82
-0.14 (-1.08%)
At close: Dec 24, 2025
Almirall Market Cap
Almirall has a market cap or net worth of €2.75 billion as of December 26, 2025. Its market cap has increased by 53.29% in one year.
Market Cap
2.75B
Enterprise Value
2.71B
Revenue
1.09B
Ranking
n/a
PE Ratio
65.49
Stock Price
€12.82
Market Cap Chart
Since June 20, 2007, Almirall's market cap has increased from 2.37B to 2.75B, an increase of 16.11%. That is a compound annual growth rate of 0.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 2.75B | 56.64% |
| Dec 31, 2024 | 1.76B | -0.35% |
| Dec 29, 2023 | 1.76B | 7.51% |
| Dec 30, 2022 | 1.64B | -19.23% |
| Dec 30, 2021 | 2.03B | 4.44% |
| Dec 31, 2020 | 1.95B | -23.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.68B |
| Laboratorios Farmaceuticos Rovi | 3.21B |
| Faes Farma | 1.62B |
| Pharma Mar | 1.32B |
| Clínica Baviera | 763.78M |
| Oryzon Genomics | 250.75M |
| Prim, S.A. | 224.61M |
| Laboratorio Reig Jofre | 209.99M |